secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2025-08-07T23:59:59+00:00
Accession:  0001193125-25-175571
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology prices $75M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Priced 20,895,522 shares at $3.35/share and 1,492,537 pre-funded warrants at $3.3499/underlying share.
- Gross proceeds expected ~$75M, net proceeds ~$70M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to 3,358,208 additional shares.
- Offering expected to close August 8, 2025; Morgan Stanley, Goldman Sachs, BofA, TD Cowen lead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000119312525175571/0001193125-25-175571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000119312525175571/d83666d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-175571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer